Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -5.66
- Piotroski Score 3.00
- Grade Neutral
- Symbol (RAPT)
- Company RAPT Therapeutics, Inc.
- Price $2.44
- Changes Percentage (7.49%)
- Change $0.17
- Day Low $2.18
- Day High $2.45
- Year High $27.35
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $48.00
- High Stock Price Target $55.00
- Low Stock Price Target $27.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.08
- Trailing P/E Ratio -1.25
- Forward P/E Ratio -1.25
- P/E Growth -1.25
- Net Income $-116,798,000
Income Statement
Quarterly
Annual
Latest News of RAPT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Westbrook scores 21 points, Jokic has a triple-double and the Nuggets beat the Raptors 121-119
Russell Westbrook led the Denver Nuggets to a 121-119 victory over the Toronto Raptors with 21 points and strong defense. Nikola Jokic recorded his third triple-double in four games. Despite injuries,...
By AP NEWS | 19 hours ago -
Kings fall to Raptors 131-128 in OT on second night of back-to-back
In a close game, the Toronto Raptors edge out the Sacramento Kings 131-128 in overtime. Raptors' 3-point shooting led the way, while Domantas Sabonis' triple-double wasn't enough for the Kings. DeRoza...
By CBS News | 2 days ago -
Did Bronny James play tonight? Lakers-Raptors box score
The Lakers defeated the Raptors 131-125 to improve their record to 4-2. LeBron James briefly played in the game, following his debut against the Cavaliers. He is expected to join the G League's South ...
By USA Today | 3 days ago
